No Prescription |
 |
 | ||
|
Caduet Norvasc Lipitor |
|
| ||
No Prescription » Prescription Drugs 3 » Caduet Norvasc Lipitor Amlodipine is used alone or in combination with other medications to treat high blood pressure and chest pain (angina). Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart. If taken regularly amlodipine controls chest pain but it does not stop chest pain once it starts. Your doctor may prescribe a different medication to take when you have chest pain.Atorvastatin is used together with lifestyle changes (diet weight-loss exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. Atorvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body.Buildup of cholesterol and other fats along the walls of the blood vessels (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to the heart brain and other parts of the body. Lowering blood levels of cholesterol and other fats may help to decrease your chances of getting heart disease angina (chest pain) strokes and heart attacks. In addition to taking a cholesterol-lowering medication making certain changes in your daily habits can also lower your cholesterol blood levels. You should eat a diet that is low in saturated fat and cholesterol (see SPECIAL DIETARY) exercise 30 minutes on most if not all days and lose weight if you are overweight. Atorvastatin comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take atorvastatin at around the same time every day. Amlodipine comes as a tablet to take by mouth. It is usually taken once a day. To help you remember to take amlodipine take it around the same time every day. Buy Caduet Norvasc Lipitor and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Caduet Norvasc Lipitor: Product Type: Prescription Drugs 3 Caduet ( Norvasc & Lipitor Generic Amplodipine & Atorvastatin ) Caduet (Norvasc & Lipitor Generic Amplodipine & Atorvastatin) Norvasc & Lipitor Generic Amplodipine & Atorvastatin 10/10mg 30 Tablets 10/10mg 90 Tablets 10/10mg 60 Tablets 10/20mg 30 Tablets 10/20mg 60 Tablets 10/20mg 90 Tablets 10/20mg 90 Tablets 5/10mg 90 Tablets 5/10mg 30 Tablets 5/10mg 60 Tablets 5/20mg 30 Tablets 5/20mg 60 Tablets 5/20mg 90 Tablets Norvasc & Lipitor Generic Amplodipine & Atorvastatin Caduet
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
